61: Healthcare in the age of the coronavirus

BlackRock
00:28:23 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (67)

00:00 Podcast Introduction and Overview of Healthcare Impact chapter 2
00:00 Host Introduction and Context Setting
00:28 Guest Panel Announcement and Roles
01:00 Emerging Trends in European Healthcare Post‑COVID chapter 3
01:00 Global Healthcare Trends Since COVID‑19
01:32 Short‑Term Trend Reversals and Outlook
02:02 Outpatient Shift and R&D Funding Confidence
02:30 Sector‑Specific Dynamics and Funding Outlook chapter 3
02:34 Capex Cycles, Hospital Upgrades, and Government Constraints
03:04 Digital Medicine Adoption Post‑Recession
03:35 Telemedicine Usage and Patient Return to Physical Visits
04:05 Digital Health, Telemedicine, and Vaccine Development chapter 5
04:06 Digital Tools for Clinical Trials and Marketing
04:38 Vaccine Development Progress and Public Perception
05:09 mRNA Vaccine Mechanism and Manufacturing Challenges
06:12 Alternative Vaccine Platforms and Current Status
06:42 Efficacy Expectations and Elderly Immune Response Concerns
07:14 Vaccine Durability and Investment Outlook chapter 2
07:14 Vaccine Longevity Concerns and Seasonal Outlook
07:45 Macro Trends in Life Sciences and Diagnostics
08:16 Life Sciences, Diagnostics, and MedTech Opportunities chapter 3
08:16 Life Sciences Drug Development and Diagnostic Personalization
08:48 Large-Cap Pharmaceutical Valuation and Pricing Pressure
09:20 MedTech Demand Recovery and Growth Outlook
09:50 European Healthcare Landscape and Lockdown Impact chapter 2
09:50 London Lockdown Restrictions and Testing Challenges
10:20 European Healthcare Investment Themes Across Segments
10:53 US vs. Europe Investment Themes in Healthcare chapter 2
10:53 US Healthcare Investment Landscape vs. Europe
11:24 Election Timing and Policy Monitoring Focus
11:55 Upcoming US Election and Healthcare Policy Implications chapter 3
11:55 Democratic vs. Republican Election Scenarios on Healthcare
12:27 Potential Drug Pricing Reforms and Legislative Limits
12:58 Republican Election Impact on Health Policy Status Quo
13:29 Policy Scenarios and Investor Guidance Post-Election chapter 3
13:29 Policy Areas Likely to Persist Regardless of Election Outcome
14:01 Investor Focus on Companies Benefiting from Policy Continuity
14:33 Telemedicine Adoption and Hospital Investment Trends
15:04 Telehealth and Home Care Adoption chapter 2
15:04 Telehealth Adoption Trends
15:34 Outpatient and Home Care Momentum
16:05 Pandemic Impact on Healthcare Innovation chapter 3
16:05 Vaccines and Drug Development Acceleration
16:35 Second Wave Outlook and Global Path Forward
17:08 Role of Drugs for Vulnerable Populations
17:38 Private Equity in Healthcare chapter 4
17:38 Private Equity vs Public Markets in Healthcare
18:10 Investment Opportunities in Private Companies
18:41 Early-Stage and Growth Capital Focus
19:12 Biotech and Value-Based Care Themes
19:43 Thematic Investment Focus and Aging Population chapter 4
19:43 Digital Health, Pharma Outsourcing, and Medicare Advantage
20:47 Aging Population Impact on Healthcare Demand
21:18 Global Aging Trends and Spending Drivers
22:19 Chronic Conditions and Healthcare Utilization
22:49 Healthcare Future Trends chapter 4
22:49 Integrated Care Model Shift
23:21 Telemedicine and Convenient Care Locations
23:53 Outpatient Procedure Migration
24:24 Wearable Devices and Personalized Medicine
24:55 Legal Disclaimer and Regulatory Notices chapter 6
24:55 Policy Changes and Investment Opportunities
25:25 General Legal Disclaimer (UK)
26:31 Legal Notice (Singapore & Hong Kong)
27:03 Australian Regulatory Disclaimer
27:33 Latin American and Mexican Advisory Notice
28:04 Copyright and Trademark Statement

Transcript

Loading transcript...